Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by pennyDoctoron Nov 25, 2019 1:20pm

111 Views

Post# 30389988

Sept to Nov House positions

6.4 million shares traded and Annon and National bank were two big sellers. They dont seem to be putting the same pressure on the market today. The shaking is over for now IMHO. They must be trading this stock technically while RBC is the only reason this stock has maintained this range.
I am confident that the sellers will become buyers as the price moves higher. Tax loss selling maybe.

Thank you FocusN for this information. It provides some insight beyond the technical moves.

Bullboard Posts

A Look into the Future of Chronic Pain Management